DD202576A5 - Verfahren zur herstellung von cyclischen imiden - Google Patents

Verfahren zur herstellung von cyclischen imiden Download PDF

Info

Publication number
DD202576A5
DD202576A5 DD82239804A DD23980482A DD202576A5 DD 202576 A5 DD202576 A5 DD 202576A5 DD 82239804 A DD82239804 A DD 82239804A DD 23980482 A DD23980482 A DD 23980482A DD 202576 A5 DD202576 A5 DD 202576A5
Authority
DD
German Democratic Republic
Prior art keywords
group
formula
compound
substituents
benzene ring
Prior art date
Application number
DD82239804A
Other languages
German (de)
English (en)
Inventor
David R Brittain
Robin Wood
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of DD202576A5 publication Critical patent/DD202576A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DD82239804A 1981-05-12 1982-05-12 Verfahren zur herstellung von cyclischen imiden DD202576A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8114397 1981-05-12

Publications (1)

Publication Number Publication Date
DD202576A5 true DD202576A5 (de) 1983-09-21

Family

ID=10521723

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82239804A DD202576A5 (de) 1981-05-12 1982-05-12 Verfahren zur herstellung von cyclischen imiden

Country Status (25)

Country Link
US (2) US4478847A (fr)
EP (1) EP0065407B1 (fr)
JP (1) JPS57192314A (fr)
KR (1) KR830009775A (fr)
AT (1) ATE12113T1 (fr)
AU (1) AU561390B2 (fr)
CA (1) CA1182823A (fr)
DD (1) DD202576A5 (fr)
DE (1) DE3262529D1 (fr)
DK (1) DK203882A (fr)
ES (2) ES8306485A1 (fr)
FI (1) FI821579A7 (fr)
GR (1) GR75871B (fr)
HU (1) HU186016B (fr)
IE (1) IE53102B1 (fr)
IL (1) IL65604A (fr)
MW (1) MW1982A1 (fr)
NO (1) NO821557L (fr)
NZ (1) NZ200576A (fr)
PH (1) PH18101A (fr)
PL (1) PL236283A1 (fr)
PT (1) PT74876B (fr)
ZA (1) ZA822797B (fr)
ZM (1) ZM3282A1 (fr)
ZW (1) ZW7882A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU566869B2 (en) * 1982-05-11 1987-11-05 Imperial Chemical Industries Plc Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones
GB8331194D0 (en) * 1982-12-20 1983-12-29 Ici Plc Chemical process
JPS60142984A (ja) 1983-12-28 1985-07-29 Kyorin Pharmaceut Co Ltd 新規なスピロピロリジン−２，５−ジオン誘導体およびその製造法
US4567278A (en) * 1984-03-26 1986-01-28 Imperial Chemical Industries Plc Process for racemizing certain spiro compounds
GB8415635D0 (en) * 1984-06-19 1984-07-25 Ici Plc Cyclic amides
MX18021A (es) * 1988-10-18 1993-11-01 Pfizer Pro-farmacos de la 3-acil-2-oxindol-1-carboxamidasanti-inflamatorias
US4900739A (en) * 1988-10-20 1990-02-13 American Home Products Corp. Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents
US4946858A (en) * 1988-10-20 1990-08-07 American Home Products Corporation Novel spirosuccinimides as aldose reductase inhibitors and antihyperglycemic agents
FR2708606B1 (fr) * 1993-07-30 1995-10-27 Sanofi Sa Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
CA2447984A1 (fr) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Formes dosifiees presentant un noyau interne et une couche externe de formes differentes
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
RU2238272C1 (ru) * 2003-05-19 2004-10-20 Пермский государственный университет Способ получения 1-алкил-6,6-диметил-2,4-диоксо-2,3,4,5,6,7-гексагидро-1h-индол-3-спиро-2-( 1-арил-3-ароил-4-гидрокси-5-оксо-2,5-дигидропирролов)
KR101333861B1 (ko) * 2005-05-24 2013-11-28 메르크 세로노 에스. 에이. Ｃｒｔｈ２ 조정자로서 삼환계 스피로 유도체
US20080057023A1 (en) * 2006-08-29 2008-03-06 Chynn Emil W Oxygenated ophthalmic composition
RU2316557C1 (ru) * 2006-10-06 2008-02-10 Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" 6,6-диметил-8-оксо-5,6,8,9-тетрагидробензо[f]-пирроло[2,1-альфа]изохинолин-9-спиро-2-(3-ароил-4-гидрокси-1-о-гидроксифенил-5-оксо-2,5-дигидро-1н-пирролы), 6,6-диметил-8-оксо-5,6,8,9-тетрагидробензо[f]пирроло[2,1-альфа]изохинолин-9-спиро-2-(3-бензоил-4-гидрокси-1-о-гидроксифенил-5-оксо-2,5-дигидро-1н-пиррол), проявляющий анальгетическую активность и способ их получения
WO2009026240A1 (fr) * 2007-08-17 2009-02-26 Solexel, Inc. Procédé de revêtement, par transfert de liquide, de substrats 3d

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4177230A (en) * 1978-06-02 1979-12-04 The United States Of America As Represented By The Secretary Of The Air Force Process for producing reaction sintered silicon nitride of increased density
US4307108A (en) * 1979-12-26 1981-12-22 Pfizer Inc. Method for lowering sorbitol levels using spiro-imides

Also Published As

Publication number Publication date
PT74876B (en) 1983-12-07
ZW7882A1 (en) 1983-11-30
NO821557L (no) 1982-11-15
IL65604A (en) 1986-12-31
GR75871B (fr) 1984-08-02
FI821579L (fi) 1982-11-13
EP0065407A3 (en) 1983-03-16
PT74876A (en) 1982-06-01
ES512093A0 (es) 1983-06-01
FI821579A0 (fi) 1982-05-05
ZA822797B (en) 1983-07-27
EP0065407A2 (fr) 1982-11-24
NZ200576A (en) 1984-11-09
AU561390B2 (en) 1987-05-07
ATE12113T1 (de) 1985-03-15
ES8306485A1 (es) 1983-06-01
JPS57192314A (en) 1982-11-26
CA1182823A (fr) 1985-02-19
IE820928L (en) 1982-11-12
EP0065407B1 (fr) 1985-03-13
PL236283A1 (en) 1983-09-12
ZM3282A1 (en) 1982-12-21
ES519780A0 (es) 1984-03-01
AU8299482A (en) 1982-11-18
DE3262529D1 (en) 1985-04-18
DK203882A (da) 1982-11-13
IE53102B1 (en) 1988-06-22
HU186016B (en) 1985-05-28
US4478847A (en) 1984-10-23
KR830009775A (ko) 1983-12-23
MW1982A1 (en) 1984-02-08
FI821579A7 (fi) 1982-11-13
PH18101A (en) 1985-03-20
US4523021A (en) 1985-06-11
ES8402840A1 (es) 1984-03-01

Similar Documents

Publication Publication Date Title
EP0657426B1 (fr) Dérivés tricycliques de pyrrole
EP0572852B1 (fr) Quinoxalines-2,3(1H,4H)-diones utiles comme médicament
EP0148440B1 (fr) 1,3,4,5-Tétrahydrobenzo(c,d)indoles, procédé de préparation et utilisation
DE2611824A1 (de) Chinolonderivate
DE2408409A1 (de) Aroylsubstituierte naphthalinessigsaeuren
DD155988A5 (de) Verfahren zur herstellung von 2-acylaminomethyl-1,4-benzodiazepine und deren salze
DE2628475A1 (de) Halogensubstituierte 5-aroylpyrrol- 2-essigsaeure-derivate
US4523021A (en) 1'-Substituted-spiro[pyrrolidine-3,3'-indoline]-2,2',5-triones
PL141609B1 (en) Process for preparing novel derivatives of 2/1h,3h/indolones
DD158401A5 (de) Verfahren zur herstellung eines 1-substituierten spiro[imidazolidin-4,3'-indolin]-2,2',5-trions
DE2259498A1 (de) Isoindoline, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE2234651A1 (de) Eckige klammer auf 1-(p-chlorbenzoyl)5-methoxy-2-methyl-3-indol eckige klammer zu acetoxyessigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE2733817A1 (de) 2-benzylpyrrolidine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE1934172A1 (de) Neue Pyrimidinderivate und Verfahren zu ihrer Herstellung
EP0066774B1 (fr) 1,4,9,10-Tétrahydropyrazolo(4,3-e)pyrido(3,2-b)(1,4)diazépin-10-ones, procédé pour leur préparation et médicaments les contenant
EP0072960B1 (fr) Composés 1,5-diphénylpyrazolin-3-one, ainsi qu'un procédé et produits intermédiaires pour leur fabrication et médicaments contenant ces composés
EP0066378A1 (fr) Dérivés pharmaceutiques actifs de spiro-hydantoine
DE2722416A1 (de) Neue thiazolo-pyridine
DE4444815A1 (de) Thienopyridone
DE2817661A1 (de) Neue isoindolinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE2223648A1 (de) Benzodiazepin-Derivate
EP0168181B1 (fr) Amides cycliques
CH641180A5 (de) Dibenzo(a.d)cycloocten-5,12(und 6,12)-imine.
EP0045521B1 (fr) Pyrazolobenzazépines, procédé pour leur préparation et compositions pharmaceutiques les contenant
DE2722399A1 (de) Anti-inflammatorisches mittel, verfahren zu seiner herstellung und daraus hergestellte arzneimittel